Stock screener

PHAT

Conviction 12HealthcareScan · Mon, Aug 10, 2026
PHAT$8.57+0.23%
ResistanceSupportVol 14
63 bars
Vol MA14 1.99M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Phathom Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.phathompharma.com
Price8.57
Change+0.23%
Gap-0.88%
Rel volume1.62×
Avg volume1.61M
Avg $ vol15.34M
SMA 2010.24
SMA 5010.48
SMA 20012.52
Price vs 50-18.23%
Price vs 200-31.53%
MA stackbearish
50/200 cross
Supertrenddown · 10.62
RSI (14)34
MACD hist-0.27
MACD crossbear · 7d
Stoch %K / %D9 / 7
ADX (14)27
+DI / −DI12 / 29
RSI divergence
MACD divergence
ATR %+8.22%
ADR %6.20%
52w high18.08
52w low8.23
From 52w high-52.60%
Above 52w low+4.13%
New 52w highNo
SqueezeOff
Bollinger width53.41%
%B0.19
Donchian pos8.93%
Donchian high12.24
Donchian low8.21
AVWAP (52w high)11.75
vs AVWAP high-27.06%
AVWAP (52w low)8.50
vs AVWAP low+0.82%
OBV trendDown
Chaikin MF (20)-0.29
Today vs 20d1.62×
Avg vol (14d)1.99M
Avg vol (20d)1.61M
Avg $ vol (20d)15.34M
Market cap693.32M
RS 3m (vs SPY)-35.79%
RS 6m (vs SPY)-45.22%
RS line new highNo
Trend template0/8
Technical rank11.8
1 week-4.57%
1 month-32.04%
3 months-29.52%
6 months-31.88%
1 year-8.83%
YTD-45.45%
P/E-3.13
P/B-2.01
P/S3.96
P/FCF-4.15
EPS-3.03
Div yield
ROE64.27%
ROA-67.64%
Debt/Eq-0.48
Current1.92
EV/EBITDA-4.24
Gross margin87.09%
Net margin-126.35%
Rev growth216.93%
EPS growth33.82%
Price target21.50
Target upside150.88%
Analyst ratingBuy
Institutional90.01%
Ent. value675.43M
Revenue74.27M
Net income-17.58M
Gross profit59.18M
Free cash flow-167M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out79.76M
Employees371
ListedFri, Oct 25, 2019
Free float42.17M
Float %53.5%
Short interest12.12M
Days to cover9.0d
Short volume14.6%
Squeeze score74 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.08 vs −$0.15
Last surprise+46.7% beat
Setup gradeD
Conviction12 / 100
Pattern quality
Tech rank11.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance12.44
Support9.12
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PHAT

All disclosures →
No recent disclosed trades by Congress in PHAT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PHAT · 5 buys · 3 sells

InsiderSideShares
Breedlove Robert Charles
Principal Accounting Officer · Common Stock · 2026-07-14
Tax1.55K
Parikh Asit
Director · Common Stock · 2026-05-22
Gift28K
Parikh Asit
Director · Common Stock · 2026-05-22
Gift28K
Parikh Asit
Director · Common Stock · 2026-05-20
Exercise17.5K
Parikh Asit
Director · Common Stock (Right to Buy) · 2026-05-20
Disposition17.5K
Topper James N
Director · Common Stock · 2026-05-19
Other
Schroeder Theodore R
Director · Common Stock · 2026-05-19
Grant24.12K
FIELDS HEIDI
Director · Common Stock · 2026-05-19
Grant24.12K
KARBE FRANK
Director · Common Stock · 2026-05-19
Grant24.12K
Parikh Asit
Director · Common Stock · 2026-05-19
Other

SEC filings

EDGAR filings in PHAT · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.